 STATEN ISLAND, N.Y. , Aug. 12, 2021 PRNewswire -- Acurx Pharmaceuticals, Inc. NASDAQ: ACXP Acurx or the Company, a clinical stage biopharmaceutical company developing a new class of antibiotics for difficult-to-treat bacterial infections, announced today that David P. 